Astrocytes are the most abundant cells in the CNS, and have many essential functions, including maintenance of blood-brain barrier integrity, and CNS water, ion, and glutamate homeostasis. Mammalian astrogliogenesis has generally been considered to be completed soon after birth, and to be reactivated in later life only under pathological circumstances. Here, by using genetic fate-mapping, we demonstrate that new corpus callosum astrocytes are continuously generated from nestin ϩ subventricular zone (SVZ) neural progenitor cells (NPCs) in normal adult mice. These nestin fate-mapped corpus callosum astrocytes are uniformly postmitotic, express glutamate receptors, and form aquaporin-4 ϩ perivascular endfeet. The entry of new astrocytes from the SVZ into the corpus callosum appears to be balanced by astroglial apoptosis, because overall numbers of corpus callosum astrocytes remain constant during normal adulthood. Nestin fate-mapped astrocytes also flow anteriorly from the SVZ in association with the rostral migratory stream, but do not penetrate into the deeper layers of the olfactory bulb. Production of new astrocytes from nestin ϩ NPCs is absent in the normal adult cortex, striatum, and spinal cord. Our study is the first to demonstrate ongoing SVZ astrogliogenesis in the normal adult mammalian forebrain.
Introduction
Brain size quadruples and brain astroglial numbers increase 6-to 8-fold in normal mice and rats during the first 3 postnatal weeks (Agrawal et al., 1968; Bandeira et al., 2009; Chuang et al., 2011) . There are two known forebrain origins for this rapid postnatal astrogliogenesis: (1) subventricular zone (SVZ) neural progenitor cells (NPCs) give rise to both corpus callosum and cortex astrocytes, and (2) cortical astrocytes expand themselves by symmetric divisions (Levison et al., 1993; Suzuki and Goldman, 2003; Ge et al., 2012) . It has been reported, however, that, in normal circumstances, both of these astroglial recruitment mechanisms cease at the conclusion of this initial phase of rapid forebrain growth (Ling and Leblond, 1973; Sauvageot and Stiles, 2002; Ge et al., 2012) , and are reactivated in adults only under pathological circumstances, for example after neural trauma (Buffo et al., 2008; Benner et al., 2013) . In support of this conclusion, mitotically cycling astrocytes are rarely seen outside the forebrain neurogenic niches in normal adults (Buffo et al., 2008; Molofsky et al., 2012) . But in one early study, although a 2 h systemic pulse of 3 H-thymidine failed to label corpus callosum astrocytes in normal adult mice, labeled corpus callosum astroglial nuclei were detected by autoradiography after 30 d of continuous systemic 3 H-thymidine administration (McCarthy and Leblond, 1988) . The authors concluded that immature cells residing in the corpus callosum continued to divide and to give rise to astrocytes, but did not consider the alternate possibility that those labeled astrocytes had instead been generated from SVZ NPCs.
We have now reevaluated normal adult SVZ astrogliogenesis by genetic fate-mapping in mice carrying tamoxifen-inducible nestin-cre (nestin-creER T2 ) transgene and Rosa26R-STOP-EYFP recombination marker (Lagace et al., 2007) . Our results indicate that nestin ϩ SVZ NPCs continue to generate corpus callosum astrocytes during normal adulthood, at a rate that gradually declines with advancing age. Together with our observations that: (1) overall numbers of astrocytes remain constant, and (2) astroglial apoptosis occurs in the normal adult corpus callosum, our data support the concept that there is slow, continuous turnover of astrocytes in the normal adult corpus callosum, with replacement by new astrocytes generated from nestin ϩ SVZ NPCs. In addition, the SVZ continuously exports astrocytes to the rostral migratory stream (RMS). Unlike in the corpus callo-sum and the RMS, the SVZ does not give rise to new cortical or striatal astrocytes in normal adults. Moreover, no evidence of NPC-derived astrogliogenesis is detectable in the normal adult spinal cord.
Materials and Methods
Animals. C57BL/6 nestin-Cre-ER T2 transgenic mice (Lagace et al., 2007) were crossed to C57BL/6 Rosa26R-STOP-EYFP reporter transgenic mice (The Jackson Laboratory; Srinivas et al., 2001 ) to yield nestin-creER T2 /R26R-EYFP (NCER) double-transgenic mice. The nestinCre-ER T2 construct used in the C57BL/6 nestinCre-ER T2 transgenic mice has a second intronic element that enhances nestin expression specifically in NPCs, but not in endothelial cells (Zimmerman et al., 1994; Lagace et al., 2007) . GFAP:GFP transgenic mice [FVB/NTg(GFAPGFP)14Mes/J; Zhuo et al., 1997] were purchased from The Jackson Laboratory (stock no. 003257). GFAP:GFP transgenic mice were then crossed with C57BL/6 wildtype mice (obtained initially from the Jackson Laboratory) for Ͼ7 generations to produce GFAP:GFP transgenic mice on a C57BL/6 background. Both males and females were used in this study. All protocols used in these studies were preapproved by the UC Davis IACUC.
Tamoxifen administration. To genetically label nestin ϩ SVZ NPCs, 3 month postnatal NCER mice were given intraperitoneal (i.p.) tamoxifen (TM) dissolved in 10% EtOH/90% sunflower oil (v/v) at 180 mg/kg/d for 4 consecutive days. Five days of TM at this dose had previously been reported to induce maximal genetic recombination with minimal mortality (Lagace et al., 2007 ), but we found that reducing administration to 4 d further lowered lethality without compromising recombination efficacy in 3-month-old NCER mice.
Immunohistochemistry and quantification. At the termination of experiments, the mice were anesthetized with ketamine (150 mg/kg body weight, i.p.) and xylazine (16 mg/kg body weight, i.p.), and transcardially perfused with PBS, followed by 4% paraformaldehyde (PFA) in PBS. Brain tissues were isolated and postfixed with 4% PFA in PBS overnight at 4°C. Tissues were cryoprotected, sectioned and further immunostained as previously described (Sohn et al., 2012) . TUNEL (terminal deoxynucleotidyl transferase dUTP nick end labeling) staining was performed by using DeadEnd TUNEL assay kit (Promega) following the manufacturer's instructions. Primary antibodies were as follows: anti-YFP/GFP (1:500, Abcam, Ab13970), anti-GFAP (1:500, SigmaAldrich G3893; Dako, Z0334), anti-Nestin (1: 100, Santa Cruz Biotechnology sc-21249), antivimentin (1:500, Abcam, ab8979), anti-Ki67 (1:500, Abcam, ab15580), anti-EAAT1 (1:100, Abcam, Ab416), anti-EAAT2 (1:100, Abcam, Ab41621), anti-aquaporin-4 (1:50, Santa Cruz Biotechnology, Sc-20812), anti-DCX (1:50, Santa Cruz Biotechnology, Sc-8066), antiSox10 (1:50, Santa Cruz Biotechnology, Sc-17342), and anti-PECAM (1:50, Santa Cruz Biotechnology, Sc-18916). All fluorescent images were captured by laser scanning confocal microscopy (Nikon, C1). For quantification (Figs. 1-4) , cell counting in anterior, middle, and posterior corpus callosum was performed in coronal sections ϩ1.0 mm, 0.0 mm, Ϫ1.0 mm with respect to the bregma, respectively. At each coordinate, almost the entire corpus callosal area spanning 5.0 mm of mediolateral distance for the anterior and middle corpus callosum, and 6.0 mm for the posterior corpus callosum was analyzed. In Figure 1M -O, cell density was determined within each segment (500 m) of the corpus callosum relative to the distance from the corpus callosal central point, and in Figures 1D , 3 E, F, and 4B, the total cell numbers were divided by the total area of the corpus callosum examined. For quantification shown in Fig. 5 B, C, coronal brain sections ϩ1.0 mm to the bregma were used, which displayed the mediolateral extension of the posterior RMS from the anterior SVZ. In Fig. 5B , the distance (m) from SVZ dorsal corner to the most laterally positioned EYFP ϩ /GFAP ϩ cells in the posterior RMS was measured. For each marker, at least 10 sections were analyzed, and cells were identified by their DAPI labeled nuclei.
Extrapolation of net daily addition of YFP
To estimate net daily addition of fate-mapped corpus callosum astrocytes ( 
Results

Nestin
؉ SVZ NPCs give rise to astrocytes in the normal adult corpus callosum To examine SVZ-derived astrogliogenesis in the corpus callosum during normal adulthood, we fate-mapped nestin ϩ NPCs in the SVZ by administering TM to 3-month-old adult NCER mice. In mice killed 1 d after completing a series of TM administration (i.e., IP, daily injection for 4 consecutive days), fate-mapped (i.e., EYFP ϩ ) cells were restricted to the SVZ, and were not detected in neighboring corpus callosum, cortex, or striatum (Fig. 1A) , confirming a lack of ectopic recombination by nestin-creER T2 in these forebrain structures. We then mapped the progeny of EYFP ϩ cells at later time-points (40, 120 and 270 d post-TM) (Fig. 1B) . Immunohistochemical analyses were performed in coronal brain sections at three different anterior-posterior coordinates: 1.0 mm anterior, 0.0 mm, and 1.0 mm posterior to the bregma (designated as anterior, middle, and posterior corpus callosum, respectively; Fig. 1C ). With increasing time post-TM administration, increasing numbers of EYFP ϩ cells were present in all three examined positions of the corpus callosum (Fig. 1D-L) . The number of these EYFP ϩ cells was highest in the posterior and lowest in the anterior corpus callosum. We also quantified mediolateral distributions of EYFP ϩ cells to determine the extents of their migration with respect to the SVZ (Fig. 1M-O) . In the anterior and middle corpus callosum, most EYFP ϩ cells were located in close proximity to the SVZ (Fig. 1E-H, M,N ) , but in the posterior corpus callosum, EYFP ϩ cells were more widely distributed (Fig. 1I-L, O) , including EYFP ϩ cells in the medial corpus callosum, relatively far from the SVZ (Fig. 1 K, L,O) . The vast majority of EYFP ϩ cells (i.e., 93-97%) in the corpus callosum were GFAP ϩ ( Fig. 2A-C) , the remainder being GFAP Ϫ /Sox10 ϩ oligodendroglial lineage cells or doublecortin (DCX) ϩ neuroblasts (data not shown). We did not detect fate-mapped endothelial cells (Fig. 3A-D) or microglia (data not shown). These results indicated ongoing recruitment of astrocytes from the SVZ to the corpus callosum during normal adulthood. Nestin fate-mapped astrocytes in the normal adult corpus callosum do not retain immature astroglial characteristics We further examined whether these newly recruited corpus callosum GFAP ϩ cells display an immature astroglial phenotype. Vimentin is expressed by radial glia and immature astrocytes in early development and also by mature astrocytes in adults, preceding GFAP expression during normal astroglial maturation (Schnitzer et al., 1981; Pixley and de Vellis, 1984; Galou et al., 1996) 
/GFAP
Ϫ cells (Fig. 2D,E) . Nestin is another immature astroglial marker during early development, but it is not expressed by normal mature astrocytes (Kálmán and Ajtai, 2001; Sild and Ruthazer, 2011) . None of the EYFP ϩ /GFAP ϩ cells in the corpus callosum we examined expressed immunoreactive nestin (Fig.  2 F, G) . We observed abundant nestin ϩ cells in the adult corpus callosum, but they were PECAM ϩ endothelial cells (Fig 2H ) . Moreover, EYFP ϩ /GFAP ϩ cells in the corpus callosum were uniformly Ki67 Ϫ (Fig. 2K) , whereas proliferating fatemapped astroglial cells (i.e., Ki67
ϩ cells) were detectable in the SVZ (Fig. 2I,J) . Altogether, our data indicate that the fate-mapped GFAP ϩ cells in the adult corpus callosum are mature, postmitotic astrocytes, and that these fate-mapped astrocytes are derived solely from the SVZ without further expansion by proliferation in the corpus callosum.
Nestin fate-mapped astrocytes in the normal adult corpus callosum display perivascular phenotype and express glutamate transporters Some EYFP ϩ cells in the corpus callosum formed aquaporin-4 (AQP-4) ϩ perivascular contacts (Nielsen et al., 1997) with PECAM ϩ blood vessels (Fig. 3A-D) . With increasing time post-TM, the numbers of the corpus callosum EYFP ϩ /AQP-4 ϩ astrocytes progressively increased whereas the total numbers of corpus callosum blood vessels remained constant (Fig. 3E-G) . Virtually all of the EYFP ϩ astrocytes in the corpus callosum had the "star-like" shape and dense GFAP ϩ glial filaments typical of white matter fibrous astrocytes (Molofsky et al., 2012) , and expressed the astroglial-specific excitatory amino acid transporter EAAT1 (GLAST) and EAAT2 (GLT-1; Rothstein et al., 1994; Chaudhry et al., 1995;  Fig. 3H,I ). Notably, immunoreactive intensities for EAAT1 and EAAT2 were comparable between SVZ-derived (i.e., EYFP 
Astroglial turnover in the normal adult corpus callosum
The total numbers of corpus callosum astrocytes in the interval between 3 and 12 months of age did not alter, as determined by quantification of GFAP:GFP ϩ cells using GFAP: ϩ blood vessels that were in contact with EYFP ϩ /AQP4 ϩ endfeet in anterior, middle, and posterior corpus callosum with increasing time after TM. Note that at 270 d after TM, 22.5% of total blood vessels in the posterior corpus callosum were associated with EYFP ϩ /AQP4 ϩ astrocytic endfeet. H, I, Both EYFP Ϫ /GFAP ϩ (arrowheads) and EYFP ϩ /GFAP ϩ (arrows) astrocytes in the corpus callosum expressed excitatory amino acid transporters 1 (EAAT1; H ) and EAAT2 (I ), astrocyte-specific glutamate transporters. CC, Corpus callosum. Scale bars: A, 100 m; H, I, 15 m. Results are mean Ϯ SEM (n ϭ 3-4 brains).
GFP transgenic mice (Fig. 4 A, B) . Furthermore, albeit at low-frequency, we were able to detect astroglial apoptosis by TUNEL assay in the adult corpus callosum (Fig. 4C) . Together, our results indicated that astrocyte turnover takes place in the normal adult corpus callosum, with continuous provision of new astrocytes from the SVZ. As shown in Fig. 4D , addition of new astrocytes to the corpus callosum was more rapid in young than old mice, and in the posterior than anterior segment of the corpus callosum.
Robust production of RMS astrocytes from nestin
؉ SVZ NPCs during normal adulthood To explore the possibility that new astrocytes also transit from the SVZ to the RMS, we analyzed the appearance of EYFP ϩ /GFAP ϩ astrocytes at posterior ( Fig. 5A -E) and anterior ( Fig. 5F-I Fig. 5E ; 120 d post-TM), and an increase in both the lateral migration (Fig.  5B ) and the density (Fig. 5C ) of EYFP ϩ / GFAP ϩ astrocytes within the pRMS. For anterior RMS (aRMS), we analyzed both coronal (Fig. 5H,I ) and sagittal sections (Fig. 5F ,G) at 2.5 mm anterior to the bregma and 0.8 mm lateral to the midline, respectively. At 3 d post-TM, a few EYFP ϩ cells were present in the aRMS, some of which were also GFAP ϩ (Fig. 5F ). By 120 d post-TM, a robust stream of EYFP ϩ cells had become associated with the aRMS (Fig.  5G) . Most of these EYFP ϩ cells were DCX ϩ neuroblasts (Fig. 5H ), but the aRMS also contained a substantial number of EYFP ϩ / GFAP ϩ astrocytes, as seen in both sagittal (Fig. 5G) and coronal (Fig. 5I) sections. Whereas there were numerous fate-mapped DCX ϩ neuroblasts and neurons in the granule cell layer (GCL) of the olfactory bulb (data not shown), EYFP ϩ /GFAP ϩ cells, though migrating to the anterior RMS within the olfactory bulb (Fig. 5 J, K ) , failed to advance into the olfactory bulb GCL (Fig. 5L) .
Given prior reports of the presence of GFAP ϩ astroglial precursors in the RMS (Alonso et al., 2008; Alvarez-Buylla et al., 2008) and our finding that a few EYFP ϩ /GFAP ϩ cells were located along the RMS at early days post-TM, we examined proliferation of GFAP ϩ cellsintheadultRMS.NoKi67 ϩ /GFAP ϩ cellsweredetectedin the adult RMS at 3 or 7 months of age, arguing against RMS GFAP ϩ cells as a substantial source for new astrocyte production in the normal adult RMS.
Lack of nestin
؉ NPC-derived astrogliogenesis in the forebrain cortex and striatum, and in the spinal cord during normal adulthood We observed no fate-mapped astrocytes (i.e., EYFP ϩ /GFAP ϩ ) in the normal adult cortex or striatum ( Fig. 6A-D 
Discussion
The best documented function of nestin ϩ SVZ NPCs in normal adult mice is the production of neuroblasts; these migrate via the RMS to the olfactory bulb, where they contribute to olfactory learning (Sakamoto et al., 2014) . SVZ NPCs also produce oligodendroglial progenitor cells after forebrain demyelination (Menn et al., 2006; Sullivan et al., 2013) , and contribute, along with reactive astrocytes in gray and white matter, to forebrain astrogliosis following CNS trauma, ischemia, or inflammation (Buffo et al., 2008; Li et al., 2010; Robel et al., 2011; Benner et al., 2013) . So far, evidence of SVZ astrogliogenesis in normal adults has been scant. Prior retroviral lineage tracing studies in the normal adult SVZ extending to 2-3 weeks postinjection (Doetsch et al., 1999; Menn et al., 2006) documented neuronogenesis and oligodendrogenesis, but did not specifically address astrogliogenesis. Interestingly, McCarthy and Leblond (1988) reported that, although a 2 h systemic H-thymidine-labeling approach was not designed to discriminate between astroglial mitosis in the corpus callosum and mitotic labeling of SVZ progenitor cells that subsequently migrated into the corpus callosum.
In contrast, our long-term nestin fatemapping approach showed that the SVZ is a source for continuous astrogliogenesis in the normal adult corpus callosum. This conclusion was supported by the absence of Ki67 ϩ (proliferating) fate-mapped astrocytes in the corpus callosum, and the progressive accumulation of fatemapped corpus callosum astrocytes with increasing time post-TM. These newly recruited corpus callosum astrocytes formed AQP4 ϩ -labeled contacts with blood vessels and expressed the glutamate transporters EAAT1 and EAAT2. We did not detect any fate-mapped cells with immature astroglial features in the corpus callosum: all corpus callosum astrocytes, whether EYFP ϩ or EYFP Ϫ , were vimentin ϩ and no EYFP ϩ /vimentin ϩ / GFAP Ϫ cells (immature astrocytes) were present in the corpus callosum. Furthermore, no corpus callosum EYFP ϩ astrocytes in these normal adult mice expressed immunoreactive nestin.
Despite the progressive accumulation of EYFP ϩ astrocytes in the corpus callosum with increasing time post-TM, overall numbers of corpus callosum astrocytes did not increase, and fate-mapped astrocytes did not migrate into the adjacent cortex or striatum. These observations together with the occasional corpus callosum astroglial apoptosis that we documented strongly suggest ongoing astroglial replacement in the normal adult corpus callosum. Our data (Fig. 4D ) also indicate that Ͼ10% of the corpus callosum astrocytes present in normal 3-month-old mice are replaced by SVZ-derived new astrocytes over the ensuing 9 months.
SVZ NSCs differentiate into astrocytes that, in the early postnatal period, form a glial tube within the RMS (Bonfanti and Peretto, 2007; Nityanandam et al., 2012) . However, whether the SVZ continues to produce RMS astrocytes during adulthood has not been determined. Our study shows that some nestin fatemapped astrocytes, rather than entering the corpus callosum, join the astroglial latticework that outlines the RMS and guides RMS neuroblast migration (Sun et al., 2010) . It has been reported that the adult murine RMS contains cells that, by their capacity to generate neurospheres when cultured with epidermal growth factor or fibroblast growth factor-2, can be classified as neural stem cells (Gritti et al., 2002) . But because few EYFP ϩ /GFAP ϩ cells were present in either posterior or anterior RMS in mice killed a week or less post-TM (Fig. 5 D, F ) , and we saw no Ki67 ϩ /GFAP ϩ cells in the RMS at any time point, we concluded that the fate-mapped astrocytes that accumulated in the RMS at late time-points post-TM originated in the SVZ. These EYFP ϩ /GFAP ϩ astrocytes were intermingled with DCX ϩ neuroblasts (Fig. 5 H, I ). But unlike the migrating RMS neuroblasts, these fate-mapped astrocytes did not penetrate into the granule cell and periglomerular layers of the olfactory (Fig. 5L) .
In summary, our data demonstrate for the first time that there is slow, ongoing recruitment of astrocytes originating from nestin ϩ SVZ NPCs in the normal adult mammalian forebrain. It will be interesting in future to determine the relative contributions of altered rates of SVZ astrogliogenesis and of astroglial apoptosis to forebrain reactive astrogliosis, a feature of many neurodegenerative and neuroinflammatory diseases.
